Litcius/Paper detail

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Behnood Bikdeli, Mahesh V. Madhavan, David Jiménez, Taylor Chuich, Isaac Dreyfus, Elissa Driggin, Caroline Der‐Nigoghossian, Walter Ageno, Mohammad Madjid, Yutao Guo, Liang Tang, Yu Hu, Jay Giri, Mary Cushman, I. Quéré, Evangelos Dimakakos, C. Michael Gibson, Giuseppe Lippi, Emmanuel J. Favaloro, Jawed Fareed, Joseph A. Caprini, Alfonso Tafur, John Burton, Dominic P. Francese, Elizabeth Wang, Anna Falanga, Claire McLintock, Beverley J. Hunt, Alex C. Spyropoulos, Geoffrey D. Barnes, John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Gregory Y.H. Lip

2020Journal of the American College of Cardiology2,940 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntithromboticIntensive care medicineDiseaseThrombosisPandemicVenous thrombosisCoronavirus disease 2019 (COVID-19)CoronavirusInternal medicineInfectious disease (medical specialty)Venous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesAcute Myocardial Infarction Research
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up | Litcius